Search results
Results From The WOW.Com Content Network
Sculptra. Sculptra is a proprietary formulation of poly- L -lactic acid (PLLA) that is an FDA -approved dermal filler manufactured by Dermik Laboratories, which conducts the American business of Aventis Dermatology, the global dermatology unit of Aventis (of Sanofi-Aventis). PLLA was approved by the FDA on August 3, 2004, for the treatment of ...
While surgical buttock enhancements are popular, there are minimally invasive alternatives. One such alternative is Sculptra, which is an injectable solution made of Poly-L-lactic acid particles. By stimulating the body's own collagen production, the injected area begins to expand over the course of 1 – 2 months.
Injectable filler. Injectable filler (injectable cosmetic filler, injectable facial filler) is a soft tissue filler made of polysaccharides injected into the skin at different depths. They help fill in facial wrinkles, provide facial volume, and augment facial features. Side effects include bruising or infections from improper sterilisation.
Kiran Mian, MD, a dermatologist at Hudson Dermatology and Laser Surgery in New York City, dilutes Sculptra like a mixologist would dilute Campari and sweet vermouth for an Americano. When used as ...
Poly-L-lactic acid (PLLA) is the main ingredient in Sculptra, a facial volume enhancer used for treating lipoatrophy of the cheeks. PLLA is used to stimulate collagen synthesis in fibroblasts via foreign body reaction in the presence of macrophages.
Botulinum toxin produced by Clostridium botulinum (an anaerobic, gram-positive bacterium) is the cause of botulism. [25] Humans most commonly ingest the toxin from eating improperly canned foods in which C. botulinum has grown. However, the toxin can also be introduced through an infected wound.
Restylane is the trade name for a range of injectable fillers with a specific formulation of non-animal sourced hyaluronic acid (HA). In the United States, Restylane was the first hyaluronic acid filler to be approved by the U.S. Food and Drug Administration (FDA) for cosmetic injection into subdermal facial tissues. [1]
Subcutaneous administration is the insertion of medications beneath the skin either by injection or infusion. A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. The instruments are usually a hypodermic needle and a syringe.